Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions

PURPOSE: Characterize tumor burden dynamics during PD-1 inhibitor therapy and investigate the association with overall survival (OS) in advanced melanoma. EXPERIMENTAL DESIGN: The study included 107 advanced melanoma patients treated with pembrolizumab. Tumor burden dynamics were assessed on serial...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cancer Res
Main Authors: Nishino, Mizuki, Giobbie-Hurder, Anita, Manos, Michael P., Bailey, Nancy D., Buchbinder, Elizabeth I., Ott, Patrick A., Ramaiya, Nikhil H., Hodi, F. Stephen
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559305/
https://ncbi.nlm.nih.gov/pubmed/28592629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-0114
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items